Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Immix Biopharma Inc (NASDAQ: IMMX) closed the day trading at $2.50 down -2.72% from the previous closing price of $2.57. In other words, the price has decreased by -$2.72 from its previous closing price. On the day, 0.52 million shares were traded. IMMX stock price reached its highest trading level at $2.73 during the session, while it also had its lowest trading level at $2.04.
Ratios:
For a better understanding of IMMX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.32 and its Current Ratio is at 5.32. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 11 ’23 when Hsu Jason bought 31,000 shares for $4.67 per share. The transaction valued at 144,894 led to the insider holds 813,000 shares of the business.
Hsu Jason bought 25,000 shares of IMMX for $122,025 on Dec 08 ’23. The Director now owns 782,000 shares after completing the transaction at $4.88 per share. On Sep 15 ’23, another insider, Hsu Jason, who serves as the Director of the company, bought 7,000 shares for $2.49 each. As a result, the insider paid 17,396 and bolstered with 757,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMMX now has a Market Capitalization of 65991000 and an Enterprise Value of 48279520.
Stock Price History:
The Beta on a monthly basis for IMMX is 0.16, which has changed by 0.32978725 over the last 52 weeks, in comparison to a change of 0.2160933 over the same period for the S&P500. Over the past 52 weeks, IMMX has reached a high of $7.75, while it has fallen to a 52-week low of $1.40. The 50-Day Moving Average of the stock is -17.49%, while the 200-Day Moving Average is calculated to be -29.18%.
Shares Statistics:
Over the past 3-months, IMMX traded about 277.83K shares per day on average, while over the past 10 days, IMMX traded about 176570 shares per day. A total of 19.92M shares are outstanding, with a floating share count of 13.85M. Insiders hold about 47.54% of the company’s shares, while institutions hold 8.47% stake in the company. Shares short for IMMX as of 1711584000 were 388840 with a Short Ratio of 1.40, compared to 1709164800 on 264073. Therefore, it implies a Short% of Shares Outstanding of 388840 and a Short% of Float of 2.09.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 1 analysts currently analyzing and rating the stock of Immix Biopharma Inc (IMMX).On average, analysts expect EPS of -$0.23 for the current quarter, with a high estimate of -$0.23 and a low estimate of -$0.23, while EPS last year was -$0.18. The consensus estimate for the next quarter is -$0.22, with high estimates of -$0.22 and low estimates of -$0.22.
Analysts are recommending an EPS of between -$0.93 and -$0.93 for the fiscal current year, implying an average EPS of -$0.93. EPS for the following year is -$1.01, with 1 analysts recommending between -$1.01 and -$1.01.
